Prevention of memory impairment induced by post-traumatic stress disorder by cerebrolysin (cas 12656-61-0)
-
Add time:08/16/2019 Source:sciencedirect.com
Post-traumatic stress disorder (PTSD) may occur after exposure to stressful, fearful or troubling events. Until now, there is no curable medication for this disorder. Cerebrolysin is a neuropeptide, which has an important role in the treatment of vascular dementia. In this study, the probable protective effect of cerebrolysin on PTSD-induced memory impairment was investigated. To induce PTSD, the single prolonged stress (SPS) model was used. Rats were allocated into four groups: control (vehicle-treated), CBL (administrated cerebrolysin 2.5 ml/kg by intraperitoneal route for 4 weeks), SPS (as a model of PTSD and administered vehicle), and CBL-SPS (exposed to SPS and administered cerebrolysin for 4 weeks). Learning and memory were assessed using the radial arm water maze (RAWM). Results showed that SPS impaired both short- and long- term memories; and chronic cerebrolysin administration prevented such effect. Cerebrolysin also prevented decreases in hippocampal GSH levels and GSH/GSSG ratios, and increased GSSG and TBARs, levels induced by PTSD. In conclusion, a protective effect of cerebrolysin administration against SPS model of PTSD induced short- and long- term memory impairment was characterized. This protection could be accomplished, at least partly, by prevention of PTSD induced increase in oxidative stress in the hippocampus via the use of cerebrolysin.
We also recommend Trading Suppliers and Manufacturers of cerebrolysin (cas 12656-61-0). Pls Click Website Link as below: cas 12656-61-0 suppliers
Prev:Original articleCardioprotective effects of cerebrolysin (cas 12656-61-0) on the lesion severity and inflammatory factors in a rat model of isoproterenol-induced myocardial injury
Next:Effect of cerebrolysin (cas 12656-61-0) on the cerebellum of diabetic rats: An imunohistochemical study) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- cerebrolysin (cas 12656-61-0) attenuates ethanol-induced spatial memory impairments through inhibition of hippocampal oxidative stress and apoptotic cell death in rats08/22/2019
- Clinical StudyRole of cerebrolysin (cas 12656-61-0) in cervical spondylotic myelopathy patients: a prospective randomized study08/21/2019
- Ameliorative effects of cerebrolysin (cas 12656-61-0) against isoproterenol-induced myocardial injury in male rats08/20/2019
- Subchronic cerebrolysin (cas 12656-61-0) treatment alleviates cognitive impairments and dendritic arborization alterations of granular neurons in the hippocampal dentate gyrus of rats with temporal lobe epilepsy08/19/2019
- Prospective, double blinded, comparative assessment of the pharmacological activity of cerebrolysin (cas 12656-61-0) and distinct peptide preparations for the treatment of embolic stroke08/18/2019
- Effect of cerebrolysin (cas 12656-61-0) on the cerebellum of diabetic rats: An imunohistochemical study08/17/2019
- Original articleCardioprotective effects of cerebrolysin (cas 12656-61-0) on the lesion severity and inflammatory factors in a rat model of isoproterenol-induced myocardial injury08/15/2019


